|
Page 3 of 3
References
Alekel DL, St Germain A, Peterson C, Hanson K,
Stewart JW, Toda T:
Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of
perimenopausal women . Am J Clin Nutr 72:844–852, 2000.
Bahram H. Arjmandi: The Role of Phytoestrogens in the Prevention
and Treatment of Osteoporosis in Ovarian Hormone Deficiency . Journal of the American College of Nutrition, Vol. 20, No. 5, 398S–402S (2001)
Bonnic SL: AMWA position statement on osteoporosis. J Am Med Women Assoc 45:75–79,
1990.
Brzezinski A, Debi A: Phytoestrogens: the “natural” selective
estrogen receptor modulators. Eu J Obstet Gynecol Rep Biol 85:47–51, 1999.
Cosman F, Lindsay R : Selective estrogen receptor modulators:
Clinical spectrum. Endocr Rev 20:418–434, 1999.
Dempster DW, Lindsay R: Pathogenesis of osteoporosis. Lancet
341:797–801, 1996.
Johannes CB, Crawford SL, Posner JG, McKinlay
SM: Longitudinal patterns and
correlates of hormone replacement therapy use in middle-aged women . Am J
Epidemiol 140:439–452, 1994.
Mundy GR: Visions for the future in osteoporosis research. Osteoporos Int
2(Suppl): 29S–34S, 1993.
Tolstoi LG, Levin RM: Osteoporosis—the treatment controversy. Nutr
Today 27:6–12, 1992.
Wangen KE, Duncan AM, Merz-Demlow BE, Xu X,
Marcus R, Phipps WR, Kurzer MS: Effects of soy isoflavones on markers of bone turnover in
premenopausal and postmenopausal women .
J Clin Endocrinol Metab 85:3043–3048, 2000.
<< Start < Prev 1 2 3 Next > End >>
|
